Best Non Gamstop Casinos UKTài Xỉu OnlineNon Gamstop CasinosCasino Senza AutoesclusioneCasino Non AamsCasino En Ligne Sans Verification
  Program Schedule
  For session summaries click on the session titles
 
Friday, May 17 2002
 
  3:00 -- 7:00 pm Arrival and Registration
  7:30 -- 10:00 pm Welcoming Reception (private invitation only)
Saturday, May 18th 2002
  7:00 -- 8:30 am Registration and Breakfast
  8:30 -- 8:45 am Giovanna Spinella, MD --
Welcome and Opening Remarks
  8:45 -- 10:20 am Session I – Neurochemistry Associated with Pediatric Neurotransmitter Diseases Darryl C. De Vivo, MD -- Chair
  8:45 -- 9:10 am O.C. Snead, MD -- “Functional Aspects of GABA Neurotransmission”
  9:10 -- 9:40 am Teodoro Bottiglieri, PhD -- “Biogenic Amines-Metabolism and Regulation”
  9:40 -- 10:05 am O. C. Snead, MD -- “GHB: A Potential Neurotransmitter in Mammalian CNS”
  10:05 -- 10:20 am Roundtable Discussion
  10:20 -- 10:35 am Break
  10:35 -- 12:30 pm Session II – Clinical Overview of PNDs
Andrea Gropman, MD -- Chair
  10:35 -- 11:00 am Kathryn Swoboda, MD -- “Aromatic L-Amino Acid Decarboxylase Deficiency”
  11:00 -- 11:25 am George F. Hoffmann, MD -- “Tyrosine Hydroxylase Deficiency”
  11:25 -- 11:50 pm Darryl C. De Vivo, MD -- “Segawa Disease (Dominantly Inherited GTP Cyclohydrolase Deficiency)
  11:50 -- 12:15 pm Phillip Pearl, MD -- “Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency (4-Hydroxybutyric Aciduria) in Children and Adults”
  12:15 -- 12:30 pm Roundtable Discussion
  12:30 -- 1:30 pm Lunch
  1:30 -- 4:10 pm Session III -- Diagnoses and Therapeutic Intervention for PNDs
Keith Hyland, PhD -- Chair
  1:30 -- 2:00 pm George F. Hoffmann, MD -- “The Clinician’s Approach to the Diagnosis of the Patient with a Suspected PND”
  2:00 -- 2:30 pm Keith Hyland, PhD -- “The Lumbar Puncture for Diagnosis of PNDs”
  2:30 -- 2:45 pm Roundtable Discussion
  2:45 -- 3:00 pm Coffee Break
  3:00 -- 3:30 pm Blair Ford, MD -- “Therapeutic Intervention for Disorders of Biogenic Amine Metabolism”
  3:30 -- 3:55 pm Andrea Gropman, MD -- “Vigabatrin and Newer Interventions in SSADH Deficiency”
  3:55 -- 4:10 pm Roundtable Discussion
  4:10 -- 5:00 pm Summary Discussion -- “Strategy Planning for Implementation of Goals and Objectives of the PND Association”-Chaired by the Scientific Organization Committee and Invited Speakers (open to all participants)
 

5:00 pm

 Adjourn
  7:30 pm Conference Dinner (private invitation only)
  Sunday, May 19, 2002  
  7:00 -- 8:00 am Breakfast
  8:15 -- 9:50 am Session IV – Animal Models of PNDs Kathryn Swoboda, MD -- Chair
  8:15 -- 8:40 am Marc Caron, MD -- “Animal Models of Catecholamine Defects”
  8:40 -- 9:10 am K. Michael Gibson, PhD -- “New Therapeutic Insights from a Murine Model of SSADH Deficiency”
  9:10 -- 9:35 am Keith Hyland, PhD -- “The hph-1 Mouse, a Model of GTP Cyclohydrolase Deficiency”
  9:35 -- 9:50 am Roundtable Discussion
  9:50 -- 10:05 am Break
  10:05 -- 11:15 am Session V -- Future Directions for Research And Treatment of PNDs
G. Hoffmann, MD -- Chair
  10:05 -- 10:35 am Markus Grompe, MD -- “The Potential Role of Hepatocyte Repopulation in Treating PNDs”
  10:35 -- 11:05 am Clive Svendsen, PhD – “Genetic Modification of Human Neuronal Stem Cells; Implications for Brain Repair”
  11:05 -- 11:15 am Roundtable Discussion
  11:15 -- 12:10 pm Summary Discussion -- “What are the Future Objectives of the PND Association, and How Do We Coordinate to Achieve Our Goals”-Chaired by the Scientific Organizing Committee and Invited Speakers (open to all participants)
 

12:10 -- 12:25 pm

Giovanna Spinella, MD and Darryl C. De Vivo, MD --Concluding Remarks and Closing

 

12:30 pm

Adjourn
© 2003 Pediatric Neurotransmitter Disease Association | Casinos Not on Gamstop
www.pndassoc.org